Low molecular weight heparins (LMWHs) differ from unfractionated heparin (UFH) in a number of characteristics, which is probably due to differences in molecular weight distribution. From a clinical point of view the better subcutaneous bioavailability and longer biological half-life are important, ...
网络低分子肝素钙注射液 网络释义 1. 低分子肝素钙注射液 低分子肝素钙注射液(Low Molecular Weight Heparins Calcium Injection),商品名尤尼舒、速碧林。本品主要用於预防和治 … cht.a-hospital.com|基于2个网页
Low-molecular-weight Heparins General Notices (Low-molecular-mass Heparins, Ph Eur monograph 0828) Action and use Anticoagulant. Ph Eur DEFINITION Salts of sulfated glucosaminoglycans having a mass-average relative molecular mass less than 8000 and for which at least 60 per cent of the total ...
网络低分子肝素 网络释义 1. 低分子肝素 2005年第2卷关键词总汇 ... long-term survival 长期生存率low-molecular-weight heparins低分子肝素lung abscess 肺脓肿 ... www.chestjournal.org.cn|基于6个网页 例句 释义: 全部,低分子肝素 更多例句筛选
Low-molecular-weight heparins (LMWHs), for example, dalteparin, enoxaparin, among others, are anticoagulants. These drugs are used in the prophylaxis of venous thromboembolic disease (VTE) on acute or elective admission to the hospital, and they are used in the treatment of deep vein thromboses...
Low-molecular-weight heparins (LMWH) are a class of drugs used for treatment of patients with thrombosis, or blood clots, and as prophylaxis for those who are at risk of thrombosis. They are injectable drugs, usually given sub-cutaneously. Enoxaparin, dalteparin and nadroparin are all examples...
Low molecular weight heparinheparindeep vein thrombosispulmonary embolismpostoperative thromboembolismLow molecular weight heparins (LMWHs) have been prepared by means of different fragmentation or fractionation procedures with the aim of obtaining a more effective and/or safer antithrombotic agent than ...
A medication often used for patients is called low-molecular-weight heparin. Carrie L. Yuan, Pharm.D. BCPS Harborview Medical Center, Seattle, WA ”Low-molecular-weight heparins work by blockingonepart of the body's natural clotting cascades so it decreases the ability of the body to form ...
Low-molecular-weight heparins (LMWH) are a new group of parenteral anticoagulants that represent a major clinical advance in anticoagulation since the identification of unfractionated heparin (UFH) in 1922 and the introduction of the synthetic coumarin derivative, warfarin, in 1948. 55 Their predictabl...
网络低分子量肝素钙注射液 网络释义 1. 低分子量肝素钙注射液 www.chemyq.com|基于 1 个网页 例句